Your browser doesn't support javascript.
loading
Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer.
Woodford, Rachel; Loh, Yanni; Lee, Joanna; Cooper, Wendy; Marschner, Ian; Lewis, Craig R; Millward, Michael; Lord, Sally; Gralla, Richard J; Yang, James C-H; Mok, Tony; Lee, Chee K.
Afiliación
  • Woodford R; Cancer Care Centre, St George Hospital, Kogarah, Sydney, New South Wales 2217, Australia.
  • Loh Y; Cancer Care Centre, St George Hospital, Kogarah, Sydney, New South Wales 2217, Australia.
  • Lee J; Cancer Care Centre, St George Hospital, Kogarah, Sydney, New South Wales 2217, Australia.
  • Cooper W; Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia.
  • Marschner I; Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia.
  • Lewis CR; School of Medicine, Western Sydney University, Penrith, Sydney, New South Wales 2751, Australia.
  • Millward M; National Health & Medical Research Council Clinical Trials Centre, The University of Sydney, Camperdown, Sydney, New South Wales 1450, Australia.
  • Lord S; Department of Statistics, Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia.
  • Gralla RJ; Prince of Wales Hospital Clinical School, University of NSW, Randwick, Sydney, New South Wales 2031, Australia.
  • Yang JC; School of Medicine, University of Western Australia, Perth, Western Australia 6009, Australia.
  • Mok T; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Perth, Western Australia 6010, Australia.
  • Lee CK; National Health & Medical Research Council Clinical Trials Centre, The University of Sydney, Camperdown, Sydney, New South Wales 1450, Australia.
Future Oncol ; 15(20): 2371-2383, 2019 Jul.
Article en En | MEDLINE | ID: mdl-31354046
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Australia